Skip to content

Digital Lifestyle Management for Weight Loss Control After Thyroidectomy in Thyroid Cancer Patients

Validating Efficacy for Digital Lifestyle Management for Weight Loss Control After Thyroidectomy in Thyroid Cancer Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05126706
Enrollment
80
Registered
2021-11-19
Start date
2021-11-12
Completion date
2024-08-30
Last updated
2021-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight Change, Body

Keywords

Digital lifestyle management, Thyroid cancer, Total thyroidectomy, Obesity

Brief summary

Thyroid hormones play an important role in the regulation of the body's metabolism. But the relationship between thyroid hormone status and the basal metabolism rate is not absolute. Because thyroid hormone function is not the only factor of control the metabolism and it can be influenced by various factors such as physical activity and diet. Weight change after thyroidectomy is one of the concerns for thyroid cancer patients. The evidence on the bodyweight changes following thyroidectomy has not been established well. Being overweight and obese can increase the risk of developing many potential health problems, such as heart disease, diabetes, high blood pressure, and malignant disease. Recently, digital health care technology has been developed and applied for medical purposes in many clinical practices. Digital Lifestyle Management is one of the strategies that can be helpful for the obese to control their body weight by lifestyle modification. It provides comprehensive, multifactorial, intensive interventions which are delivered via the digital health care mobile service Noom application. The aim of this study is to evaluate the efficacy of digital lifestyle management on body weight and quality of life after total thyroidectomy in thyroid cancer patients by using the digital health care Noom application.

Detailed description

The present study is a prospective randomized control trial. A total of 80 patients who underwent total thyroidectomy for thyroid cancer is included. Fifty-four patients are randomly assigned to the digital lifestyle management group and the other 26 patients are assigned to the non-digital lifestyle management group. In the experimental group (digital lifestyle management group), the patients will use this application for the first 4 months with Noom applications with 1:1 personalized coaching intervention, and then, use this app by self-help program without coaching intervention. The digital lifestyle management program will record the patient's meals, exercise, steps taken, reading articles, and give feedback to each patient. In order to monitor the psychological state and quality of life of the patients, online questionnaires will be provided. In the control group (non-digital lifestyle management group), the patients will get the conventional postoperative care protocol without using the Noom application. To investigate the weight change and quality of life, variables are collected at baseline, 4 months, and 6 months after surgery.

Interventions

BEHAVIORALDigital lifestyle management

Digital lifestyle management for Weight Loss Control after Thyroidectomy

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Target: Among the patients who have undergone thyroidectomy, patients who are interested in weight management and can use the Noom app by themselves or with the help of neighbors. * The patient has 23 or more BMI at the time of enrollment. * In The Situational Motivation Scale (SIMS), a total of five stages of synchronization level of 68 or higher, which is the top 40% of the 112 points (1st stage: pre-consumption stage; stage 2: deliberation stage; stage 3: preparation stage; stage 4: action stage) * The patient agreed about participating in this study.

Exclusion criteria

* The patient was diagnosed with chronic diseases (hepatic disease, kidney disease, diabetes, etc.). * In the case where there is no member who can support among family members, * The patient who is not a smartphone or has difficulty using digital technology. * When it is difficult to lose weight (pregnancy and pregnancy preparation, breastfeeding, and less than 12 months after childbirth) * If the patient has a history of psychiatric illness (eating disorder, depression, etc.). * If the patient is taking diet-related drugs or health supplements, or treatments. * If there is a restriction on physical activity (not allowed to exercise for more than 30 minutes a day).

Design outcomes

Primary

MeasureTime frameDescription
Weight changebaseline, 4 months, 6 monthsChange from baseline weight at 4 months and 6 months after surgery

Secondary

MeasureTime frameDescription
Changes of results about questionnaires for quality of life (Korean Obesity Quality of Life (KOQOL))baseline, 4 months, 6 monthsChange from baseline results of questionnaires at 4 months and 6 months after surgery \# Korean Obesity Quality of Life (KOQOL) * Range: 4-60 * Higher scores: impaired QOL
Changes of results about questionnaires for quality of life (World Health Organization Quality of Life - Brief Form (WHOQOL-Bref))baseline, 4 months, 6 monthsChange from baseline results of questionnaires at 4 months and 6 months after surgery \# World Health Organization Quality of Life - Brief Form (WHOQOL-Bref) * Range: 0-100 * Higher scores: higher QOL
Changes of results about questionnaires for quality of life (Pittsburgh Sleep Quality Index (PSQI))baseline, 4 months, 6 monthsChange from baseline results of questionnaires at 4 months and 6 months after surgery \# Pittsburgh Sleep Quality Index (PSQI) * Range: 0-21 * Lower scores: a healthier sleep quality
Changes of results about questionnaires for quality of life (Korean-Beck Depression Inventory-II (K-BDI-II))baseline, 4 months, 6 monthsChange from baseline results of questionnaires at 4 months and 6 months after surgery \# Korean-Beck Depression Inventory-II (K-BDI-II) * Range: 0-63 * Higher scores: Depression
Changes of results about questionnaires for quality of life (State-Trait Anxiety Inventory (STAI))baseline, 4 months, 6 monthsChange from baseline results of questionnaires at 4 months and 6 months after surgery \# State-Trait Anxiety Inventory (STAI) * Range: 20-80 * Higher scores: anxiety
Changes of results about questionnaires for quality of life (Rosenberg Self-Esteem Scale (RSES))baseline, 4 months, 6 monthsChange from baseline results of questionnaires at 4 months and 6 months after surgery \# Rosenberg Self-Esteem Scale (RSES) * Range: 0-30 * Higher scores: lower self-esteem
Changes of results about questionnaires for quality of life (Body Shape Questionnaire (BSQ-8C) )baseline, 4 months, 6 monthsChange from baseline results of questionnaires at 4 months and 6 months after surgery \# Body Shape Questionnaire (BSQ-8C) * Range: 8-48 * Higher values: body dissatisfaction
Changes of results about questionnaires for quality of life (Dutch Eating Behaviour Questionnaire (DEBQ))baseline, 4 months, 6 monthsChange from baseline results of questionnaires at 4 months and 6 months after surgery \# Dutch Eating Behaviour Questionnaire (DEBQ) * Range: 33-165 * Higher scores: the eating behavior
Changes of waist circumstancebaseline, 4 months, 6 monthsWaist circumstance difference
Changes of body fat percentbaseline, 4 months, 6 monthsBody fat percent difference
Changes of hip circumstancebaseline, 4 months, 6 monthsHip circumstance difference
Changes of total cholesterol levelbaseline, 4 months, 6 monthsBiological index
Changes of HDL cholesterol levelbaseline, 4 months, 6 monthsBiological index
Changes of LDL cholesterol levelbaseline, 4 months, 6 monthsBiological index
Changes of triglyceride levelbaseline, 4 months, 6 monthsBiological index
Changes of aspartate aminotransferase (AST) levelbaseline, 4 months, 6 monthsBiological index
Changes of alanine aminotransferase (ALT) levelbaseline, 4 months, 6 monthsBiological index
Changes of gamma-glutamyl transferase (GGT) levelbaseline, 4 months, 6 monthsBiological index
Changes of free T3 levelbaseline, 4 months, 6 monthsBiological index
Changes of free T4 levelbaseline, 4 months, 6 monthsBiological index
Changes of TSH levelbaseline, 4 months, 6 monthsBiological index
Changes of lean body massbaseline, 4 months, 6 monthsLean body mass difference

Countries

South Korea

Contacts

Primary ContactKyu Eun Lee
kyueunlee@snu.ac.kr+821092738292
Backup ContactJungHak Kwak
jhkwak908@gmail.com+821040700477

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026